91
Views
12
CrossRef citations to date
0
Altmetric
Expert Opinion

Managing infertility with the follitropin alfa prefilled pen injector – patient considerations

Pages 995-1001 | Published online: 29 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Guy De Mesmaeker, Brigitte Calles & Judith A Smith. (2023) Analysis of Nurse and Patient Preferences for Pre-Filled Pen Devices for Self-Injection of Highly Purified Human Menopausal Gonadotropin (HP-hMG, MENOPUR®). Patient Preference and Adherence 17, pages 1281-1292.
Read now
Vassilis Fragoulakis, Andreas Mantis, Nikolaos Christoforidis, Dimitrios Dovas, Spyros Deftereos, Tryfwnas Lainas, Evripidis Mantoudis, Thanos Paraschos, Dimitris Sakellariou & Evangelos Makrakis. (2022) Follitropin Alpha for assisted reproduction: an analysis based on a non-interventional study in Greece. Current Medical Research and Opinion 38:12, pages 2227-2235.
Read now
Pierre Zitoun, Jaya Parikh, Martine Nijs, Wenjie Zhang, Rachel Levy-Toledano & Boxiong Tang. (2019) Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets. International Journal of Women's Health 11, pages 11-21.
Read now
Joan Schertz & Hilary Worton. (2018) Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey. Expert Opinion on Drug Delivery 15:5, pages 435-442.
Read now
Mary Mahony, Andrea Dwyer, Raschelle Barkume, Allison Strochlic, Fabien Jeannerot & Thomas Stüdeli. (2018) US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use. Expert Opinion on Drug Delivery 15:1, pages 5-15.
Read now
Joan Schertz & Hilary Worton. (2017) Patient evaluation of the redesigned follitropin alfa pen injector. Expert Opinion on Drug Delivery 14:4, pages 473-481.
Read now
Fabien Jeannerot, Thomas Stüdeli, Lisa Gunther-LaVergne, David Hirning & Joan Schertz. (2016) Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment. Expert Opinion on Drug Delivery 13:9, pages 1221-1229.
Read now

Articles from other publishers (5)

Chao Chin Hsu, Isabel Hsu, Hui Hua Chang, Rosie Hsu & Sonam Dorjee. (2022) Extended Injection Intervals of Gonadotropins by Intradermal Administration in IVF Treatment. The Journal of Clinical Endocrinology & Metabolism 107:2, pages e716-e733.
Crossref
Chao-Chin Hsu, Leonard Hsu, Yuan-Shuo Hsueh, Chih-Ying Lin, Hui Hua Chang & Chao-Tien Hsu. (2021) Ovarian Folliculogenesis and Uterine Endometrial Receptivity after Intermittent Vaginal Injection of Recombinant Human Follicle-Stimulating Hormone in Infertile Women Receiving In Vitro Fertilization and in Immature Female Rats. International Journal of Molecular Sciences 22:19, pages 10769.
Crossref
Peter Sydow, Norbert Gmeinwieser, Katrin Pribbernow, Christoph Keck & Inka Wiegratz. (2020) Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study. Reproductive Biology and Endocrinology 18:1.
Crossref
Wilhelmina Bagchus, Özkan Yalkinoglu & Peter Wolna. (2018) Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris®) in Pituitary-Suppressed Healthy Women. Frontiers in Endocrinology 8.
Crossref
Martin Kathrins & Craig Niederberger. (2016) Diagnosis and treatment of infertility-related male hormonal dysfunction. Nature Reviews Urology 13:6, pages 309-323.
Crossref